US FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

·

·

US FDA grants orphan drug status to AstraZeneca's asthma drug Fasenra

(Reuters) – AstraZeneca said on Wednesday that the U.S. Food and Drug Administration has granted orphan drug status to its severe asthma drug, Fasenra, to treat eosinophilic oesophagitis (EoE). EoE, also known as allergic oesophagitis, is an allergic …
See Original Article

Nigeria Fears Fiscal Crisis as Debts Take Big Slice of Revenue

Africa's largest oil producer could run out of money if it doesn't boost revenues urgently. Nigeria's President Muhammadu Buhari warned that the
See Original Article

Google is facing another EU antitrust probe – this time over its jobs search tool

Google has faced a combined $9.5 billion in antitrust fines from the European Union over the past two years. Now, yet another EU antitrust case is brewing — this time over its jobs search tool “Google for Jobs.” In a speech Tuesday, EU Competition …
See Original Article

Key yield curve inverts even further as 30-year yield hits new record low

A key part of the U.S. yield curve inverted even further Wednesday morning, exacerbating fears of an impending recession. U.S. Markets Overview: Treasurys chart. TICKER, COMPANY, YIELD, CHANGE, %CHANGE. US 3-MO, U.S. 3 Month Treasury, 1.971 …
See Original Article

Japanese automakers Toyota, Suzuki to form capital tie-up

TOKYO (Reuters) – Toyota Motor Corp (7203.T) and Suzuki Motor Corp (7269.T) will form a capital alliance, the Japanese carmakers said on Wednesday, as they look to accelerate technological development and meet sweeping changes upending the global …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.